Eczema, a chronic inflammatory skin condition, significantly impacts patients’ quality of life through persistent itching and ...

Network meta-analysis of five studies compares chronic hand eczema monotherapies, ranking ten treatments by HECSI score improvement to inform selection of FDA approved and emerging options.

Anzupgo (R) (delgocitinib cream) is currently approved in Canada, United States, European Union, United Kingdom, Switzerland and the United Arab Emirates under the brand name Anzupgo (R) for the ...

If you’ve ever experienced eczema, or you know someone who has, you’re probably familiar with the physical effects of itchy, irritated skin. But the chronic condition can take a major mental toll, too ...

WATCH: November is eczema awareness month, Dr. Melinda Gooderham is a dermatologist and chronic hand eczema clinical ...

San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Hand Eczema pipeline constitutes 5+ key companies continuously working towards developing 5+ ...

The trial met its primary endpoint with a significantly larger proportion of delgocitnib-treated patients achieving treatment success. Delgocitinib cream significantly improved chronic hand eczema in ...

LEO Pharma Inc., a global leader in dermatology, is pleased to announce the availability of Anzupgo® (delgocitinib cream) ...

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, announces today that it has enrolled the first patients in two new phase 2b clinical studies to investigate ...

This piece is part of Bustle's My Life With, which is all about removing the invisibility around living with a chronic illness. “皮肤太难堪,” the nurse at the hospital in Chongqing, China, said to me.